A. Cortot

发表

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

N. Barnich, C. Neut, P. Desreumaux, 1998, Gastroenterology.

J. Boudeau, C. Neut, P. Desreumaux, 2001, Gut.

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

Mourad Sahbatou, Pierre Laurent-Puig, Jean-Pierre Hugot, 2001, Nature.

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice

G. Rogler, C. Neut, P. Desreumaux, 2013, Mucosal Immunology.

The efficacy and safety of a third anti‐TNF monoclonal antibody in Crohn’s disease after failure of two other anti‐TNF antibodies

P. Rutgeerts, S. Vermeire, G. Van Assche, 2010, Alimentary pharmacology & therapeutics.

Villous adenomas of the rectum. Results of endoscopic treatment with argon and Nd:YAG lasers.

J. Paris, A. Cortot, F. Rancé, 1985, Gastroenterology.

Endoscopic laser treatment for rectosigmoid villous adenoma: factors affecting the results.

B. Boniface, J. Paris, A. Cortot, 1989, Gastroenterology.

Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).

L. Dauchet, F. Vasseur, J. Salleron, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study

É. Lerebours, D. Turck, J. Colombel, 2005, Gut.

Long‐term outcome of treatment with infliximab in pediatric‐onset Crohn's disease: A population‐based study

F. Vasseur, A. Duhamel, J. Salleron, 2011, Inflammatory bowel diseases.

Specific antibody response to oligomannosidic epitopes in Crohn's disease

P. Jacquinot, J. Colombel, D. Poulain, 1996, Clinical and diagnostic laboratory immunology.

Anti-Saccharomyces cerevisiae Mannan Antibodies in Familial Crohn's Disease

O. Goulet, J. Colombel, D. Poulain, 1998, American Journal of Gastroenterology.

Impact of surgery on quality of life in Crohn's disease.

Y. Yazdanpanah, P. Marquis, P. Desreumaux, 1997, The American journal of gastroenterology.

Transdermal nicotine decreases mucosal IL-8 expression but has no effect on mucin gene expression in ulcerative colitis.

W. Sandborn, P. Desreumaux, M. Capron, 1998, Inflammatory bowel diseases.

Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.

M. Neunlist, L. Dubuquoy, P. Desreumaux, 2014, American journal of physiology. Gastrointestinal and liver physiology.

Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease

C. Neut, O. Carrette, A. Cortot, 1995, Digestive Diseases and Sciences.

An in-depth study of Crohn's disease in two French families

R. Cartun, R. Whitlock, J. Paris, 1993, Gastroenterology.

Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation.

P. Ducrotte, J. Paris, A. Cortot, 1987, Gastroenterology.

Better Outcome of Patients Undergoing Enteral Tube Feeding After Myeloablative Conditioning for Allogeneic Stem Cell Transplantation

I. Yakoub-Agha, A. Duhamel, A. Cortot, 2012, Transplantation.

Incidence, Clinical Presentation and Location at Diagnosis of Pediatric Inflammatory Bowel Disease: A Prospective Population-Based Study in Northern France (1988-1999)

S. Auvin, É. Lerebours, D. Turck, 2005, Journal of pediatric gastroenterology and nutrition.

Molecular form of faecal alpha 1 antitrypsin in patients with Crohn's disease.

J. Colombel, A. Cortot, C. Mizon, 1992, Gut.

Familial and Sporadic Inflammatory Bowel Disease: Different Entities?

S. Vermeire, A. Cortot, J. Colombel, 2000, Inflammatory bowel diseases.

The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10‐ to 19‐year‐old age bracket (1988–2007)

V. Chouraki, L. Dauchet, G. Savoye, 2011, Alimentary pharmacology & therapeutics.

Biofeedback for the treatment of fecal incontinence

M. Lamblin, A. Cortot, C. Gower-Rousseau, 1995, Diseases of the colon and rectum.

Virulence factors of escherichia coli strains isolated from ileal mucosa in Crohn's disease (CD)

N. Barnich, C. Neut, P. Desreumaux, 1998 .

Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study

L. Dauchet, F. Vasseur, J. Salleron, 2013, Gut.

P. Desreumaux, M. Capron, A. Janin, 1998, Clinical immunology and immunopathology.

Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

P. Desreumaux, M. Capron, A. Janin, 1995, Gut.

Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10.

E. Leteurtre, W. Sandborn, P. Desreumaux, 2000 .

Activated eosinophils in adult coeliac disease: evidence for a local release of major basic protein.

M. Capron, G. Torpier, A. Janin, 1992, Gut.

Differentiation and identification of human faecal anaerobic bacteria producing β-galactosidase (a new methodology)

C. Neut, J. Colombel, A. Cortot, 1996 .

Hepatic steatosis revealing celiac disease: a case complicated by transitory liver failure.

J. Colombel, A. Cortot, L. Devisme, 1996, The American journal of gastroenterology.

Colonic Inflammation in Mice Is Improved by Cigarette Smoke through iNKT Cells Recruitment

C. Neut, B. Bertin, L. Dubuquoy, 2013, PloS one.

Endoscopic fluorescence imaging for the study of anastomotic recurrences in Crohn's disease (CD) correlation with histological findings

S. Mordon, P. Desreumaux, J. Colombel, 1999 .

Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease.

P. Desreumaux, M. Capron, J. Colombel, 1997, Gastroenterology.

A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.

H. Tilg, A. Kaser, P. Rutgeerts, 2003, Gut.

A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis

H. Tilg, A. Kaser, P. Rutgeerts, 2003 .

Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects.

A. Cortot, M. Romond, C. Romond, 1998, Journal of dairy science.

Perioperative endoscopy of the whole small bowel in Crohn's disease.

J. Colombel, J. Paris, A. Cortot, 1993, Gut.

Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

R. Modigliani, J. Mary, J. Gendre, 1990, Gastroenterology.

Intestinal antiinﬂammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor- (cid:1)

J. Auwerx, W. Wahli, P. Chavatte, 2005 .

Insulin in the Somogyi Phenomenon

B. Wallaert, A. Tonnel, C. Voisin, 1985 .

Clinical characteristics of Crohn's disease in 72 families.

J. Belaiche, J. Hugot, R. Modigliani, 1996, Gastroenterology.

Environmental Factors in Familial Crohn's Disease in Belgium

P. Rutgeerts, S. Vermeire, R. Vlietinck, 2005, Inflammatory bowel diseases.

Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease

C. Neut, J. Colombel, A. Cortot, 1997, Digestive Diseases and Sciences.

The Natural History of Pediatric Ulcerative Colitis: A Population-Based Cohort Study

L. Dauchet, G. Savoye, É. Lerebours, 2009, The American Journal of Gastroenterology.

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

M. Dubinsky, D. Rubin, D. Wolf, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evidence of lymphocyte alveolitis in Crohn's disease.

B. Wallaert, J. Colombel, A. Tonnel, 1985, Chest.

Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein.

A. Capron, M. Capron, G. Torpier, 1988, Clinical and experimental immunology.

Clinical predictors at diagnosis of disabling pediatric Crohn's disease

A. Duhamel, J. Salleron, G. Savoye, 2012, Inflammatory bowel diseases.

Antibiotics in Crohn's disease

A. Cortot, J. Colombel, H. V. Van Kruiningen, 2001, Gut.

Cyclosporine treatment of steroid‐refractory ulcerative colitis during pregnancy

M. De Vos, P. Marteau, P. Seksik, 2009, Inflammatory bowel diseases.

Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms.

B. Wallaert, A. Tonnel, C. Voisin, 1986, Chest.

Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

X. Marchandise, B. Wallaert, J. Colombel, 1986, Gut.

[Human anisakiasis: 5 cases in northern France].

E. Dei‐Cas, A. Cortot, R. Marti, 1986, Gastroenterologie clinique et biologique.

P. Marquis, J. Colombel, J. Gendre, 2001, American Journal of Gastroenterology.

Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease.

P. Desreumaux, M. Capron, A. Janin, 1995, Gut.

Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis.

P. Desreumaux, M. Capron, A. Janin, 1996, Gastroenterology.

Probiotics in inflammatory bowel disease: a critical review.

P. Desreumaux, J. Colombel, A. Cortot, 2003, Best practice & research. Clinical gastroenterology.

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy.

E. Louis, J. Reimund, L. Peyrin-Biroulet, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group.

D. Jewell, P. Rutgeerts, P. Rutgeerts, 1999, Gastroenterology.

Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis (UC): influence of disease activity and familial study.

J. Colombel, L. Noël, D. Reumaux, 1993, Advances in experimental medicine and biology.

[Infliximab therapy for Crohn's disease anoperineal lesions].

R. Modigliani, B. Flourié, F. Carbonnel, 2008, Gastroenterologie clinique et biologique.

lnterferon‐α in combination with corticosteroids improves systemic mast cell disease

P. Desreumaux, A. Janin, A. Cortot, 1995, The British journal of dermatology.

Pre‐operative management is associated with low rate of post‐operative morbidity in penetrating Crohn’s disease

F. Pruvot, A. Cortot, J. Colombel, 2010, Alimentary pharmacology & therapeutics.

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

D. Jewell, M. Vatn, F. T. Veloso, 1998, The New England journal of medicine.

AIEC colonization and pathogenicity: Influence of previous antibiotic treatment and preexisting inflammation

C. Neut, E. Singer, P. Desreumaux, 2012, Inflammatory bowel diseases.

Increased pulmonary and intestinal permeability in Crohn's disease.

X. Marchandise, B. Hecquet, B. Wallaert, 1992, Gut.

Growth hormone enhances fat-free mass and glutamine availability in patients with short-bowel syndrome: an ancillary double-blind, randomized crossover study.

F. Gottrand, A. Duhamel, B. Messing, 2014, The American journal of clinical nutrition.

[Incidence of inflammatory bowel disease in the Nord-Pas-de-Calais region and the Somme area of France in 1988].

É. Lerebours, J. Colombel, J. Paris, 1990, Gastroentérologie Clinique et Biologique.

Incidence of inflammatory bowel disease in northwestern France. Preliminary results in region Nord-Pas-de-Calais.

R. Beuscart, J. Colombel, J. Paris, 1989, Scandinavian journal of gastroenterology. Supplement.

A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.

G. Savoye, J. Reimund, É. Lerebours, 2010, Gastroenterologie clinique et biologique.

Familial Crohn's Disease in Belgium: Pedigrees, Temporal Relationships Among Cases, and Family Histories

P. Rutgeerts, S. Vermeire, R. Vlietinck, 2007, Journal of clinical gastroenterology.

[Epidemiology and risk factors of inflammatory bowel diseases].

J. Colombel, A. Cortot, C. Gower-Rousseau, 2005, Bulletin de l'Academie nationale de medecine.

Anti-neutrophil cytoplasmic autoantibodies in relatives of patients with ulcerative colitis.

J. Colombel, L. Noël, D. Reumaux, 1992, Gastroenterology.

[Incidence of inflammatory bowel diseases in children in the Nord-Pas-de-Calais region].

F. Gottrand, J. Colombel, L. Moreno, 1991, Archives francaises de pediatrie.

Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study

P. Varlet, I. Iwanicki-Caron, C. Elie, 2017, Journal of Crohn's & colitis.

Long-term Outcome After First Intestinal Resection in Pediatric-onset Crohn's Disease: A Population-based Study

A. Duhamel, J. Salleron, G. Savoye, 2013, Inflammatory bowel diseases.

Incidence of inflammatory bowel disease in northern France (1988-1990).

J. Colombel, A. Cortot, J. Colombel, 1994, Gut.

Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.

J. Ledent, P. Varlet, I. Iwanicki-Caron, 2018, Inflammatory bowel diseases.

Space-time clusters of Crohn’s disease in northern France

C. Preda, F. Vasseur, A. Duhamel, 2013, Journal of Public Health.

Anti‐Neutrophil Cytoplasmic Auto‐Antibodies (ANCA) in Ulcerative Colitis (UC): No Relationship with Disease Activity

D. Heresbach, J. Colombel, D. Reumaux, 2000, Inflammatory bowel diseases.

Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn’s disease

O. Goulet, J. Colombel, D. Poulain, 1998 .

Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis.

J. Colombel, J. Paris, L. Gambiez, 2006, Gastroenterologie clinique et biologique.

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

J. Hugot, B. Bonaz, J. Rey, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

P137 Long-term outcome of paediatric-onset Crohn's disease: A population-based study

J. Salleron, G. Savoye, L. Peyrin-Biroulet, 2012 .

Early Surgery is Not Associated With Poor Prognosis in Pediatric Crohn's Disease: A Population-Based Study

J. Salleron, G. Savoye, É. Lerebours, 2011 .

Fontolizumab in moderate to severe Crohn's disease: A phase 2, randomized, double‐blind, placebo‐controlled, multiple‐dose study

P. Rutgeerts, D. Hommes, C. Bernstein, 2010, Inflammatory bowel diseases.

Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999)

É. Lerebours, J. Colombel, B. Grandbastien, 2004, Gut.

Comparison of budesonide and 5‐aminosalicylic acid enemas in active distal ulcerative colitis

R. Modigliani, P. Rutgeerts, M. Lémann, 1995, Alimentary pharmacology & therapeutics.

Epidemiology of inflammatory bowel disease: is there a "Belgian-French exception?".

J. Colombel, B. Grandbastien, A. Cortot, 1996, Acta gastro-enterologica Belgica.

Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis

O. Dewit, G. D'Haens, X. Hébuterne, 2008, The American Journal of Gastroenterology.

Pouchitis Is Associated with Mucosal Imbalance Between Interleukin‐8 and Interleukin‐10

E. Leteurtre, W. Sandborn, P. Desreumaux, 2000, Inflammatory bowel diseases.

Treatment of diversion colitis by short-chain fatty acids

C. Neut, J. Paris, A. Cortot, 1991, Diseases of the colon and rectum.

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

H. Tilg, A. Kaser, P. Rutgeerts, 2003, Gut.

EVIDENCE OF GASTRITIS WITH SEVERAL HELICOBACTER PYLORI STRAINS

H. Leclerc, A. Cortot, P. Vincent, 1989, The Lancet.

Efficacy of Diosmectite (Smecta)® in the Treatment of Acute Watery Diarrhoea in Adults: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

A. Cortot, T. Najjar, H. Mathiex-Fortunet, 2011, Gastroenterology research and practice.

The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ

B. Bertin, L. Dubuquoy, P. Desreumaux, 2013, Carcinogenesis.

Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine

J. Belaiche, B. Bonaz, B. Flourié, 2003, Alimentary pharmacology & therapeutics.

Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn’s Disease Recurrence

L. Peyrin-Biroulet, P. Desreumaux, P. Blanc, 2016, Journal of Crohn's & colitis.

Methotrexate in Crohn's disease: long-term efficacy and toxicity.

R. Modigliani, J. Cosnes, Y. Bouhnik, 2000 .

Methotrexate in Crohn's disease: long-term efficacy and toxicity

R. Modigliani, J. Cosnes, Y. Bouhnik, 2000, American Journal of Gastroenterology.

Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease.

G. Huet, P. Desreumaux, A. Janin, 1999, European journal of gastroenterology & hepatology.

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life.

D. Jewell, M. Vatn, F. T. Veloso, 2002 .

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life

D. Jewell, M. Vatn, F. T. Veloso, 2002, American Journal of Gastroenterology.

Effect of intrajejunal elemental diet perfusion on jejunal secretion of immunoglobulins, albumin, and hyaluronan in man.

R. Modigliani, J. Colombel, R. Hällgren, 1992, Gut.

Hyperbaric oxygenation in severe perineal Crohn's disease

D. Mathieu, A. Cortot, J. Colombel, 1995, Diseases of the colon and rectum.

Cap polyposis occurring in the postoperative course of pelvic surgery.

J. Colombel, A. Cortot, H. V. Van Kruiningen, 1994, Gut.

Placebo‐controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease

J. Belaiche, R. Modigliani, É. Lerebours, 1996, European journal of gastroenterology & hepatology.

Bacterial translocation in patients with colorectal cancer.

H. Leclerc, L. Fournier, J. Colombel, 1988, The Journal of infectious diseases.

Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease

A. Duhamel, L. Peyrin-Biroulet, P. Desreumaux, 2009, Inflammatory bowel diseases.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

F. Carrat, N. Brousse, J. Faivre, 2009, The Lancet.

YOGHURT WITH BIFIDOBACTERIUM LONGUM REDUCES ERYTHROMYCIN-INDUCED GASTROINTESTINAL EFFECTS

C. Neut, A. Cortot, J. Colombel, 1987, The Lancet.

Subcorneal pustular dermatosis in a patient with Crohn's disease.

A. Cortot, J. Colombel, E. Delaporte, 1992, Acta dermato-venereologica.

Post-operative recurrence of Crohn’s disease after definitive stoma: an underestimated risk

A. Duhamel, J. Salleron, B. Pariente, 2017, International Journal of Colorectal Disease.

Epidemiology and natural history of inflammatory bowel diseases.

Philippe Seksik, Jacques Cosnes, P. Seksik, 2011, Gastroenterology.

[Comparative effectiveness of ranitidine (150 mg X 2) and cimetidine (400 mg x 2) in the treatment of acute duodenal ulcer. A French multicenter controlled clinical trial].

M. Henry-Amar, J. Paris, A. Cortot, 1987, Gastroenterologie clinique et biologique.

Effect of intrajejunal elemental diet perfusion on local secretion of soluble CD4 and CD8

P. Desreumaux, M. Capron, J. Colombel, 1996, Clinical and experimental immunology.

Lasers in rectosigmoid cancers: factors affecting immediate and long-term results.

B. Boniface, A. Adenis, J. Paris, 1989, Bailliere's clinical gastroenterology.

Hidradenitis suppurativa and Crohn's disease in two families: a significant association?

J. Colombel, J. Paris, A. Cortot, 1992, The American journal of gastroenterology.

Bipolar electrocoagulation treatment for hemorrhagic radiation injury of the lower digestive tract.

A. Cortot, J. Brunetaud, V. Maunoury, 1991, Gastrointestinal endoscopy.

The importance of familial clusterings in Crohn's disease.

J. Colombel, A. Cortot, J. Colombel, 2001, Inflammatory bowel diseases.

Immunocytochemical evidence of Listeria, Escherichia coil, and Streptococcus antigens in Crohn's disease☆

A. West, R. Cartun, A. Cortot, 1995, Gastroenterology.

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

Jean Weissenbach, Laurent Beaugerie, Pierre Laurent-Puig, 1996, Nature.

Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.

R. Modigliani, J. Mary, É. Lerebours, 1992, Gastroenterology.

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

A. Forbes, S. Travis, G. D'Haens, 2006, Gut.

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ

J. Auwerx, W. Wahli, D. Metzger, 2005, The Journal of experimental medicine.

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease.

J. Auwerx, P. Desreumaux, M. Capron, 1999, Gastroenterology.

Natural history of pediatric Crohn's disease: a population-based cohort study.

Julia Salleron, Dominique Turck, J. Salleron, 2008, Gastroenterology.

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease

D. Jewell, M. Vatn, F. T. Veloso, 1998 .

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

S. Targan, D. Poulain, B. Grandbastien, 1998, Gut.

[Blue rubber bleb nevus syndrome. 3 cases treated with a Nd:YAG laser and bipolar electrocoagulation].

D. Turck, J. Paris, A. Cortot, 1990, Gastroenterologie clinique et biologique.

Action ofin situ nitroglycerin on upper anal canal pressure of patients with terminal constipation

M. Lamblin, A. Cortot, F. Guillemot, 1993, Diseases of the colon and rectum.

Natural history of eosinophilic gastroenteritis.

P. Desreumaux, J. Colombel, A. Cortot, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists

A. Cortot, M. Mignon, J. Delchier, 1986, Digestive Diseases and Sciences.

What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease?

J. Colombel, A. Cortot, C. Tamboli, 2003, European journal of gastroenterology & hepatology.

Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. G.E.T.A.I.D.

J. Hugot, P. Laurent-Puig, L. Beaugerie, 1994, American journal of medical genetics.

[Acute pancreatitis associated with corticosteroid treatment in Crohn's disease].

P. Cuingnet, J. Colombel, A. Cortot, 2003, Gastroenterologie clinique et biologique.

Inflammatory bowel disease in spouses and their offspring.

S. Vermeire, É. Lerebours, J. Colombel, 2001, Gastroenterology.

Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease

C. Neut, P. Desreumaux, J. Colombel, 2002, American Journal of Gastroenterology.

Qualitative study of fecal alpha 1-proteinase inhibitor in normal subjects and patients with Crohn's disease.

J. Colombel, A. Cortot, P. Degand, 1988, Clinical chemistry.

[Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].

S. Chaussade, J. Colombel, A. Cortot, 1991, Gastroenterologie clinique et biologique.

Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease

P. Rutgeerts, K. Lauritsen, J. Colombel, 2001, Gut.

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

L. Peyrin-Biroulet, P. Sogni, J. Nousbaum, 2008, Alimentary pharmacology & therapeutics.

[Epidemiology and risk factors of inflammatory bowel diseases].

J. Colombel, A. Cortot, C. Gower-Rousseau, 2005, La Revue du praticien.

Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease.

P. Desreumaux, J. Colombel, L. Gambiez, 1995, The American journal of gastroenterology.

Perioperative endoscopy of the whole small bowel in Crohn's disease.

J. Colombel, J. Paris, A. Cortot, 1993, Gut.

Infectious agents and Crohn's disease.

P. Desreumaux, A. Darfeuille‐Michaud, A. Cortot, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Speciﬁc Antibody Response to Oligomannosidic Epitopes in Crohn’s Disease

D. Poulain, A. Cortot, J. Colombel, 1996 .

The relationship of granulomas to blood vessels in intestinal Crohn's disease.

A. West, A. Matson, R. Cartun, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.

J. Colombel, J. Paris, L. Noël, 1992, Gastroenterologie clinique et biologique.

IgM-specific measles-virus antibody in families with a high frequency of Crohn's disease

J. Colombel, A. Cortot, S. Dubucquoi, 1995, The Lancet.

Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

J. Colombel, A. Cortot, N. Viget, 2005, Inflammatory bowel diseases.

Endoscopic palliation for inoperable malignant dysphagia: long term follow up.

B. Boniface, J. Paris, A. Cortot, 1992, Gut.

Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis

J. Colombel, A. Lebas, M. Rogosnitzky, 2014, Techniques in Coloproctology.

[Gastric metastasis of a malignant melanoma of the choroid].

J. Colombel, J. Paris, A. Cortot, 1984, Gastroenterologie clinique et biologique.

Anticipation in familial Crohn’s disease

D. Franchimont, P. Rutgeerts, R. Vlietinck, 1998, Gut.

Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium.

J. Colombel, A. Cortot, C. Gower-Rousseau, 1994, Gut.

Virus serology in familial Crohn disease.

E. Vanopdenbosch, J. Colombel, A. Cortot, 2000, Scandinavian journal of gastroenterology.

Impaired bacterial flora in human excluded colon.

C. Neut, J. Paris, A. Cortot, 1989, Gut.

Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions

B. Wallaert, P. Desreumaux, R. Iacob, 2006, Alimentary pharmacology & therapeutics.

Inflammatory boweldisease inmarried couples: 10cases inNordPasdeCalais region ofFrance andLiege county ofBelgium

A. Cortot, C. Gower-Rousseau, 1994 .

CROHN'S DISEASE IN A MARRIED COUPLE AND THEIR FOUR CHILDREN

J. Colombel, J. Paris, A. Cortot, 1989, The Lancet.

[Crohn's disease and ulcerative colitis].

A. Cortot, B. Vigneron, 2011, La Revue du praticien.

Oxidative and synthetic functions of n-butyrate in colonocytes

C. Neut, J. Colombel, A. Cortot, 1992, Diseases of the colon and rectum.

Stressful Life Events as a Risk Factor for Inflammatory Bowel Disease Onset: A Population-Based Case–Control Study

É. Lerebours, J. Colombel, S. Debeugny, 2007, The American Journal of Gastroenterology.

Nutritional Status and Growth in Pediatric Crohn's Disease: A Population-Based Study

F. Vasseur, B. Merlin, G. Savoye, 2010, The American Journal of Gastroenterology.

P078 Nutritional Status and Growth in Pediatric Crohn's Disease (CD): A Population Based Study

F. Vasseur, B. Merlin, G. Savoye, 2009 .

Mapping of inflammatory bowel disease in northern France: Spatial variations and relation to affluence

C. Declercq, A. Duhamel, J. Salleron, 2010, Inflammatory bowel diseases.

Pneumocystis jiroveci (carinii) pneumonia after initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.

H. Melliez, J. Colombel, A. Cortot, 2005, Inflammatory bowel diseases.

Thiopurine S-methyltransferase genotyping does not predict azathioprine-induced myelosuppression in Crohn's disease

C. Libersa, J. Colombel, F. Broly, 2003 .

[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].

O. Dewit, R. Modigliani, P. Marteau, 2002, Gastroenterologie clinique et biologique.

P0720 INCIDENCE AND PRESENTATION OF PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) AT DIAGNOSIS. A PROSPECTIVE POPULATION-BASED STUDY IN NORTHERN FRANCE (1988???1999)

S. Auvin, É. Lerebours, D. Turck, 2004 .

Mycophenolate mofetil (MMF) in refractory Crohn's disease after failure of treatments by azathioprine (AZA) or methotrexate (MTX)

O. Dewit, R. Modigliani, P. Marteau, 2008 .

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies.

L. Dauchet, L. Peyrin-Biroulet, J. Colombel, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sa1246 Clinical and Phenotypic Characteristics of Crohn's Disease in Elderly People: A Population-Based Study

L. Dauchet, J. Salleron, G. Savoye, 2012 .

[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease].

É. Lerebours, B. Grandbastien, A. Cortot, 1999, Revue d'epidemiologie et de sante publique.

[What is the prognosis in unclassified colitis? Results of a cohort study of 104 patients in the Northern-Pas-de-Calais region].

J. Colombel, A. Cortot, C. Gower-Rousseau, 1993, Gastroenterologie clinique et biologique.

NATURAL HISTORY OF CROHN'S DISEASE IN CHILDREN: A POPULATION-BASED COHORT STUDY IN NORTHERN FRANCE

É. Lerebours, D. Turck, J. Colombel, 2006 .

[Laser treatment of rectosigmoid villous tumors. Study of a series of 313 patients].

J. Paris, A. Cortot, J. Brunetaud, 1990, Annales de Chirurgie.

Villous adenomas of the rectum

J. Paris, A. Cortot, F. Rancé, 1985 .

Association of coeliac disease and portal venous thrombosis.

P. Desreumaux, J. Colombel, A. Cortot, 1995, Gastroenterologie clinique et biologique.

Functional assessment of coloanal anastomosis with reservoir and excision of the anal transition zone

J. Leroy, M. Lamblin, A. Cortot, 1991, Diseases of the colon and rectum.

Palliative treatment for oesophagogastric cancer by laser photocoagulation

J. Paris, A. Cortot, J. Brunetaud, 1990, Lasers in Medical Science.

Palliative Treatment for Esophagogastric Cancer by Laser Photoablation

J. Paris, A. Cortot, J. Brunetaud, 1990 .

Use of Lasers in Nonbleeding Gastrointestinal Lesions: A European Experience

A. Cortot, J. Brunetaud, V. Maunoury, 1988 .

Sweet's syndrome associated with Crohn's disease.

J. Colombel, A. Cortot, E. Delaporte, 1989, Acta dermato-venereologica.

Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.

J. Colombel, A. Cortot, G. Pineton de chambrun, 2011, Journal of Crohn's & colitis.

S1186 Incidence of Microscopic Colitis in Northern France

A. Duhamel, J. Salleron, G. Savoye, 2010 .

Mixed adenocarcinoid tumor and Crohn's disease.

P. Desreumaux, J. Colombel, L. Gambiez, 1998, Journal of clinical gastroenterology.

Parameters affecting laser palliation in patients with advanced digestive cancers

B. Boniface, J. Paris, A. Cortot, 1989, Lasers in surgery and medicine.

Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease.

C. Neut, J. Colombel, A. Cortot, 1997, Digestive diseases and sciences.

[Campylobacter pylori and gastric acidity].

H. Leclerc, J. Colombel, J. Paris, 1988, Gastroentérologie Clinique et Biologique.

[Fundic endocrine tumors and atrophic gastritis: the value of antrectomy].

E. Leteurtre, J. Triboulet, J. Wemeau, 2002, Gastroenterologie clinique et biologique.

[Diarrhea and functional digestive pathology].

A. Cortot, 1989, La Revue du praticien.

Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.

J. Colombel, A. Cortot, B. Fournet, 1992, Clinical science.

Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer.

J. Colombel, J. Paris, A. Cortot, 1988, Gastroenterologie clinique et biologique.

[Cutaneous manifestations of zinc deficiency in ethylic cirrhosis].

A. Cortot, V. Dumur, F. Piette, 1987, Annales de dermatologie et de vénéréologie.

[Treatment of diversion colitis with short-chain fatty acids. Bacteriological study].

C. Neut, A. Cortot, J. Colombel, 1995, Gastroentérologie Clinique et Biologique.

Eosinophilic Enteritis

P. Desreumaux, A. Cortot, G. Pineton de Chambrun, 2015, Digestive Diseases.

Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.

M. Diebold, A. Cortot, M. Bigard, 1998, Digestive diseases and sciences.

Thromboembolism as the first symptom of Menetrier's disease.

A. Adenis, J. Paris, A. Cortot, 1992, American Journal of Gastroenterology.

Crohn's disease: beyond antagonists of tumor necrosis factor

J. Chayvialle, A. Cortot, 2009 .

Crohn's disease

J. Chayvialle, A. Cortot, 2003 .

Long-term omeprazole monotherapy is ineffective against Helicobacter pylori infection.

A. Adenis, J. Paris, A. Cortot, 1992 .

Lasers in rectosigmoid tumours

J. Paris, A. Cortot, J. Brunetaud, 1990, Lasers in Medical Science.

Laser palliation for rectosigmoid cancers

J. Paris, A. Cortot, J. Brunetaud, 2005, International Journal of Colorectal Disease.

Thiopurine S-methyltransferase deficiency associated with a novel mutation.

J. Colombel, J. Jouet, A. Cortot, 2010, Inflammatory bowel diseases.

[Role of antibiotics in Crohn's disease].

P. Desreumaux, J. Colombel, E. Lederman, 1999, Gastroenterologie clinique et biologique.

Bacterial translocation in colorectal cancers.

J. Triboulet, L. Fournier, J. Colombel, 1990, Gastroenterologie clinique et biologique.

Lymphangiectasia in Waldmann's disease.

A. Cortot, V. Maunoury, C. Plane, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

M1190 Natural History of Eosinophilic Gastroenteritis

J. Colombel, A. Cortot, F. Gonzalez, 2009 .

Long-Term Treatment with Omeprazole in Seven Patients with Zollinger-Ellison Syndrome Resistant to H2-Antagonists

K. A. Lloyd-Davies, A. Cortot, M. Mignon, 1986 .

European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

A. Forbes, G. D'Haens, P. Gionchetti, 2006, Gut.

Invasive ability of escherichia coli strains isolated from ileal mucosa in Crohn's disease (CD)

J. Boudeau, C. Neut, P. Desreumaux, 2000 .

Superoxide anion generation by alveolar macrophages in Crohn's disease.

B. Wallaert, A. Tonnel, C. Voisin, 1985, The New England journal of medicine.

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study

I. Iwanicki-Caron, F. Vasseur, G. Savoye, 2016, Gut.